In this June update, we've made four adjustments to the KBC Securities Dynamic Top Pick List: 1.Merus (Removed – 27 May) was removed following the release of strong interim Phase 2 data at the ASCO 2025 conference. Its lead asset, petosemtamab, in combination with Keytruda, showed a 63% overall response rate in first-line treatment of head and neck cancer—significantly outperforming Keytruda monotherapy. The resulting share price surge validated our investment thesis. 2. Adyen (Removed) has de...
Azerion publishes Interim Unaudited Financial Results Q1 2025 Quarterly Report Q1 2025 .. 4th consecutive Q1 Year-on-Year growth Highlights of Q1 Throughout Q1 2025 we have continued our multi-year focus on efficiency and profitability; favouring long-term economic decisions over short-term opportunities. We have continued to invest in the platform and this is reflected in the performance outlined below, resulting in several record achievements since our listing early 2022: Total Revenue of € 128.0 million in Q1 2025, up 7% from € 119.7 million in Q1 2024 and the 4th consecutive Q1...
Azerion Launches Open and Independent Multi-Cloud and AI Platform Amsterdam, 22 May 2025 – Azerion, the leading European digital advertising company, is launching its new Multi-Cloud and AI platform, Azerion Intelligence. In a time where independence, open choices and scalable AI compute power are more relevant than ever, Azerion offers European businesses affordable, independent cloud hosting, access to open-source AI capabilities, and a marketplace of AI-powered apps and agents tailored for digital marketing and publishing. This new platform by Azerion enables AI-enhanced business so...
CFE's 1Q25 trading update underscored our view that end market conditions remain challenging in the short-to-medium term. Revenue declined by c.10% YoY in 1Q25 and the company reiterated its FY25 guidance, expecting a moderate decline in top line but a net profit close to the level reached last year. This was a positive and highlights that project-specific issues no longer significantly impact the underlying profitability of CFE. Our new, now in line with company guidance, FY25F net profit estim...
Annual and Extraordinary General Meeting 2025 DEME (Euronext: DEME) held its Annual and Extraordinary General Meeting today at the DEME headquarters. Reference is made to the agendas as shared in the convening notice. The shareholders have approved all agenda items of both the Annual and the Extraordinary General Meeting. Attachment
Jaarlijkse en Buitengewone Algemene Vergadering DEME (Euronext: DEME) heeft vandaag zijn Jaarlijkse en Buitengewone Algemene Vergadering gehouden in het hoofdkantoor van DEME. Er wordt verwezen naar de agenda's zoals vermeld in de oproeping. De aandeelhouders hebben alle agendapunten van zowel de Jaarlijkse als de Buitengewone Algemene Vergadering goedgekeurd. Bijlage
Reportedly, Bayer thinks about sending Monsanto into chapter 11 to solve litigation|Teva: Moody’s upgrades the rating to Ba1/stable from Ba2/positive|Techem Q2 25 call notes: Likely no imminent call of EUR 750 Temporary Notes|Crédit Logement released its 2024 results|BFCM announces the call for its Perp CMS on 16/06/2025|
Reportedly, Bayer thinks about sending Monsanto into chapter 11 to solve litigation|Teva : Moody’s rehausse le rating de Ba2/positive à Ba1/stable|Techem Q2 25 call notes: Likely no imminent call of EUR 750 Temporary Notes|Crédit Logement a publié ses résultats 2024|BFCM annonce le call de son Perp CMS à la date du 16/06/2025|
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.